Citigroup
OPTR

Citigroup’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Citigroup’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-121,600
Closed -$1.76M – 7229
2013
Q2 		$1.76M Buy
+121,600
New +$1.77M ﹤0.01% 2461

Citigroup's OPTR Position: Q4 2013 in Review

Citigroup sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 10,456 shares — an estimated $132K sold.

Citigroup first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $483K in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Citigroup reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Citigroup sold 10,456 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $132K.
  • Citigroup first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Citigroup's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $483K in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Citigroup's 13F filing for Q4 2013, filed 14 Feb 2014.